Veterinary Medicine Information website

NOBILIS RISMAVAC+CA126 CONCENTRADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA POLLOS

Authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Download as PDF

Product identification

Medicine name:
NOBILIS RISMAVAC+CA126 CONCENTRADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA POLLOS
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Target species:
  • Chicken
  • Chicken (embryonated eggs)
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • In ovo

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    3.00
    plaque forming unit
    /
    1.00
    Dose
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
    3.00
    plaque forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
  • In ovo
    • Chicken (embryonated eggs)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 1226 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 14/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 14/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 21/06/2024
Download